# Orchestra BioMed (OBIO) — Overview

OBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/obio

## Price

Last close $5.47 on Oct 16, 2026. 52-week range $3.32 – $6.35.

## Company profile

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $32.0M |
| Revenue (quarter) | $88,000.00 |
| Revenue growth (year over year) | -89.47% |
| Gross profit (trailing twelve months) | $31.8M |
| Gross margin | 99.51% |
| Net income (trailing twelve months) | −$59.0M |
| Net income (quarter) | −$23.8M |
| Net income growth (year over year) | -22.68% |
| Net margin | -184.60% |
| Return on equity | -400.96% |
| EPS (trailing twelve months) | −$0.84 |
| Book value per share | $0.49 |
| P/E (trailing twelve months) | — |
| Price to book | 11.2 |
| Debt to assets | 74.57% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Orchestra BioMed (OBIO) profitable?

No. Orchestra BioMed reported a net loss of $59.0M over the trailing twelve months.

### How much revenue does Orchestra BioMed (OBIO) make?

Orchestra BioMed generated $32.0M in revenue over the trailing twelve months, down 89.47% year over year.

### How do I buy stock in Orchestra BioMed (OBIO)?

OBIO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).